In a landmark move toward medical independence, the Africa Centres for Disease Control and Prevention (Africa CDC) and the African Medicines Agency (AMA) have officially synchronized their operations.
The partnership aims to dismantle the continent’s reliance on external medical supplies by establishing a harmonized health infrastructure capable of meeting the needs of over 1.4 billion people.
A Unified Vision for Self-Reliance
The collaboration follows high-level joint guidance issued by Africa CDC Director-General Dr. Jean Kaseya and AMA Director-General Dr. Delese Mimi Darko. Technical teams from both institutions recently convened to bridge the gap between regulatory oversight and emergency response, ensuring that Africa can manufacture, regulate, and distribute its own life-saving treatments.
“Together, we’re building a resilient, harmonized health infrastructure,”the agencies stated in a joint briefing. “This partnership marks a new chapter in advancing Africa’s health future.”
The Three Pillars of the Partnership
To ensure the success of this initiative, the joint task force has identified three “core technical priorities” designed to streamline how medicine is handled across borders:
-
Continental Quality Assurance: Developing a unified policy to govern the procurement of medical supplies under the African Pooled Procurement Mechanism (APPM), ensuring that only high-standard, safe medications enter the market.
-
Prioritized Medical Listing: Establishing clear, transparent procedures for determining which medical products receive continental listing, effectively fast-tracking essential drugs and vaccines for use in all member states.
-
Local Manufacturing Support: Providing direct assistance to African producers through the AMA SME & Innovation Office and the Africa CDC Business Acumen Facility, turning local startups into industrial powerhouses.
Strengthening the Supply Chain
By aligning the African Pooled Procurement Mechanism with the regulatory rigor of the AMA, the continent is moving toward a bulk buying model. This strategy is expected to lower costs for member states and provide a guaranteed market for local manufacturers, making it economically viable to produce vaccines and essential medicines on African soil.
This strategic alignment is viewed by experts as the missing piece in Africa’s pandemic preparedness strategy, shifting the focus from reactive aid to long-term health sovereignty.
Share this
